Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

WOUND-ACT Multifunctional Wound Dressing with Stimuli-Responsive Drug Release and Antibacterial Action

Coordinator
Fundacion Imdea Materiales, Spain
Runs
1 November 2026 to 31 October 2028
Status
Running
EU funding
€194k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101273240

What the project is doing

In the project's own words, from its summary on CORDIS.

Chronic wounds, including pressure ulcers and burns, pose a persistent global healthcare challenge, particularly among ageing and immobilised patients. Chronic wounds frequently exhibit impaired healing, a phenomenon attributable to a complex microenvironment characterised by chronic inflammation, persistent infection, poor vascularisation, and impaired tissue regeneration. Despite the considerable advances made in the field of medicine, current wound dressings are passive and largely ineffective in responding to these multifactorial conditions.

There is an absence of the capacity to dynamically adapt, monitor local changes, or deliver therapeutic agents in a controlled manner. This results in delayed healing, recurrent infections, and significant healthcare costs. WOUND-ACT proposes a novel strategy to address these limitations through the design of a smart, multi-layered and multifunctional wound dressing capable of real-time wound monitoring and stimuli-responsive therapeutic drug release.

The system is composed of three distinct layers, each with a specific function: (i) an inner antibacterial GeIMA-based hydrogel with ZnO particles doped with Ag or Mg, designed to suppress microbial colonization and biofilm formation; (ii) a central electroresponsive GeIMA-based hydrogel reinforced with carbon nanotubes and therapeutic nanocapsules, enabling on-demand drug delivery triggered by wound conditions; and (iii) an outer sensing layer that uses colorimetric indicators to detect pH and temperature changes associated with infection or inflammation.

This integrated platform combines diagnostics and therapy in a single modular system that is adaptable to diverse wound types, healing stages, and patient profiles. The clinical scalability of the design is of significant potential, with the capacity to reduce healing times, minimise antibiotic use, reduce readmissions and substantially reduce healthcare costs. This marks a disruptive advance in personalised wound care.

Who is involved

OrganisationCityCountryRole
Fundacion Imdea MaterialesGetafeSpainCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI